Pharming Group NV

PHAR · NASDAQ · Healthcare / Biotechnology

12.60USD-0.35 (-2.70%)

Price History

Full chart

Market Stats

Previous Close12.95

Open12.69

Day Range12.49 – 13.07

52-Week Range9.62 – 21.34

Volume5.07K

Market Cap740.34M

P/E (TTM)74.71

Forward P/E212.77

EPS0.14

Dividend Yield0.00%

Beta0.07

50-Day Avg11.56

200-Day Avg14.70

About

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.
Employees407
HeadquartersDarwinweg 24, Leiden, Netherlands, 2333 CR, USA
Websitehttps://www.pharming.com

Leadership

Mr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.CEO & Executive Director
Mr. Kenneth Lynard EMBA, M.Sc.Chief Financial Officer · b. 1968
Ms. Mireille Sanders M.Sc.Chief Operations Officer · b. 1968
Mr. Michael K. LevitanVP of Investor Relations & Corporate Communications
Mr. Ruud Van Outersterp L.L.M.Chief Legal & Compliance Officer and Company Secretary · b. 1964
Ms. Ines Bernal B.A.Chief People Officer
Dr. Anurag Relan M.D., MPHChief Medical Officer · b. 1972
Dr. Alexander Breidenbach M.B.A., Ph.D.Chief Business Officer · b. 1963
Ms. Leverne Marsh BPHARMChief Commercial Officer
Dr. Magnus HanssonMedical Director · b. 1976

Financials

Income Statement

Currency: USD	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	596.70K	479.68K	194.01K	1.01M	924.35K	479.97K	762.07K	3.89M	14.04M	9.45M	25.76M	11.84M	16.69M	107.52M	154.58M	189.39M	212.17M	198.87M	205.62M	245.32M	297.20M	376.13M
Growth (%)	-	-19.61%	-59.55%	+418.54%	-8.12%	-48.08%	+58.77%	+410.06%	+261.10%	-32.67%	+172.60%	-54.05%	+41.01%	+544.06%	+43.77%	+22.52%	+12.03%	-6.27%	+3.39%	+19.30%	+21.15%	+26.56%
Cost of Revenue	5.28M	6.17M	5.83M	36.90M	1.44M	5.08M	122.36K	4.58M	5.64M	1.54M	4.17M	5.25M	4.93M	14.93M	25.37M	23.93M	23.54M	21.14M	17.56M	25.21M	35.40M	45.50M
Gross Profit	-4.68M	-5.69M	-5.69M	-35.90M	-769.45K	-4.02M	639.71K	-688.23K	8.39M	7.92M	21.60M	6.59M	11.77M	92.59M	129.20M	165.46M	188.63M	177.73M	188.06M	220.10M	261.80M	330.63M
Gross Margin	-784.69%	-1187.16%	-2931.56%	-3568.26%	-83.24%	-836.96%	83.94%	-17.71%	59.79%	83.75%	83.82%	55.67%	70.50%	86.11%	83.59%	87.37%	88.91%	89.37%	91.46%	89.72%	88.09%	87.90%
Operating Expense	8.60M	16.15M	18.11M	0	40.25M	35.88M	28.78M	23.29M	31.48M	17.46M	18.10M	20.62M	23.91M	66.30M	85.74M	97.22M	112.38M	158.72M	178.20M	242.39M	265.47M	309.75M
Operating Income	-13.28M	-21.84M	-23.80M	-35.90M	-41.02M	-39.90M	-28.14M	-23.98M	-23.09M	-9.54M	3.50M	-14.03M	-12.14M	26.29M	43.46M	68.25M	76.26M	19.01M	9.86M	-22.29M	-3.67M	20.88M
Operating Margin	-2226.19%	-4553.34%	-12267.39%	-3568.26%	-4437.80%	-8312.84%	-3692.15%	-616.91%	-164.52%	-100.99%	13.58%	-118.53%	-72.70%	24.45%	28.12%	36.03%	35.94%	9.56%	4.80%	-9.09%	-1.23%	5.55%
EBITDA	-12.23M	-19.11M	-21.17M	-27.81M	-23.25M	-33.58M	-48.95M	-22.85M	-28.43M	-16.13M	-6.80M	-9.31M	-13.88M	-76.33M	24.85M	71.46M	58.35M	48.78M	33.53M	9.88M	16.32M	34.78M
EBITDA Margin	-2049.31%	-3984.70%	-10914.33%	-2764.49%	-2514.91%	-6997.02%	-6422.69%	-587.86%	-202.56%	-170.72%	-26.39%	-78.62%	-83.12%	-70.99%	16.08%	37.73%	27.50%	24.53%	16.31%	4.03%	5.49%	9.25%
Net Income	-12.98M	-21.15M	-24.41M	-31.55M	-36.48M	-45.93M	-66.78M	-22.17M	-31.86M	-20.80M	-7.01M	-10.89M	-18.44M	-91.47M	28.59M	40.56M	37.75M	16.00M	13.67M	-10.55M	-11.84M	2.85M
Net Income Margin	-2175.81%	-4409.64%	-12582.36%	-3136.38%	-3946.54%	-9570.15%	-8763.53%	-570.32%	-227.01%	-220.05%	-27.22%	-91.96%	-110.48%	-85.08%	18.50%	21.41%	17.79%	8.04%	6.65%	-4.30%	-3.98%	0.76%
R&D	5.00M	10.57M	17.38M	27.83M	30.74M	35.19M	24.35M	17.92M	25.88M	14.13M	14.18M	15.50M	16.18M	22.38M	33.04M	31.79M	38.52M	70.37M	52.53M	68.91M	83.15M	100.37M
R&D as % of Total Revenue	837.83%	2202.72%	8960.58%	2766.38%	3326.06%	7331.35%	3194.94%	461.15%	184.41%	149.50%	55.05%	130.96%	96.94%	20.82%	21.37%	16.78%	18.15%	35.38%	25.55%	28.09%	27.98%	26.68%
Interest Expense	8.22K	10.66K	2.37M	1.69M	9.68M	11.87M	1.15M	276.07K	3.43M	3.29M	212.80K	981.78K	6.40M	45.41M	16.37M	13.35M	10.31M	7.00M	5.36M	5.96M	9.05M	10.72M
Interest Expense % of Total Revenue	1.38%	2.22%	1222.87%	167.83%	1046.86%	2472.84%	150.96%	7.10%	24.45%	34.76%	0.83%	8.29%	38.32%	42.23%	10.59%	7.05%	4.86%	3.52%	2.61%	2.43%	3.04%	2.85%

Balance Sheet

Currency: USD	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	40.96M	104.37M	166.72M	93.40M	80.07M	49.59M	32.01M	22.28M	43.37M	67.75M	63.06M	133.34M	199.38M	214.48M	255.91M	342.55M	450.44M	425.80M	462.85M	414.18M	499.81M
Total Liabilities	-	6.93M	38.59M	83.55M	75.96M	60.99M	36.16M	33.55M	32.40M	36.45M	31.46M	33.84M	104.45M	176.82M	152.73M	138.53M	192.39M	231.73M	221.16M	244.07M	185.27M	222.79M
Total Equity	-	28.63M	65.78M	50.58M	17.45M	19.07M	14.45M	-1.54M	-10.12M	5.01M	29.84M	23.84M	27.47M	16.11M	61.75M	117.39M	150.16M	218.71M	204.64M	218.78M	228.91M	277.02M
Cash	-	17.40M	34.42M	74.29M	27.30M	22.81M	13.70M	4.90M	6.97M	23.43M	41.57M	34.60M	33.54M	70.37M	80.31M	74.35M	167.94M	217.59M	207.34M	61.74M	56.89M	146.02M
Total Debt	-	223.85K	2.08M	22.92M	52.57M	41.96M	238.65K	4.45M	3.78M	2.72M	1.93M	15.87M	67.39M	82.21M	83.42M	58.20M	132.58M	183.39M	166.69M	171.54M	116.30M	115.78M
Net Debt	-	-17.17M	-32.34M	-51.37M	25.27M	19.15M	-10.18M	-445.86K	-3.20M	-20.71M	-39.63M	-18.73M	33.86M	27.16M	3.11M	-16.15M	-35.36M	-34.20M	-40.65M	109.80M	59.41M	-30.25M

Cash Flow

Currency: USD	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-9.40M	-15.26M	-25.42M	-31.69M	-14.21M	-23.54M	-3.15M	-21.94M	-13.58M	-11.45M	-3.13M	-17.95M	-10.52M	45.84M	46.34M	74.15M	83.63M	37.84M	22.46M	-17.30M	-1.79M	54.71M
Investing Cash Flow	-4.72M	-3.43M	-4.22M	-978.32K	-1.13M	6.02M	-1.21M	-1.18M	142.83K	332.79K	-670.05K	-981.78K	-60.45M	-7.25M	-4.31M	-28.26M	-15.63M	-21.30M	5.32M	-129.39M	31.62M	26.25M
Financing Cash Flow	31.48M	10.29M	45.38M	84.04M	-26.19M	3.54M	17.15M	13.59M	15.30M	29.12M	18.44M	15.70M	70.81M	-3.91M	-20.55M	-63.47M	60.69M	-27.95M	-4.98M	-1.04M	-34.41M	1.50M
Capital Expenditure	499.84K	1.02M	4.16M	978.32K	1.13M	435.56K	1.21M	1.37M	812.02K	29.00K	187.26K	981.78K	1.59M	7.25M	4.31M	25.45M	15.30M	16.72M	1.98M	1.46M	796.00K	755.00K
Free Cash Flow	-9.90M	-16.28M	-29.58M	-32.67M	-31.63M	-35.23M	-5.41M	-21.71M	-14.39M	-11.48M	-6.61M	-18.94M	-12.11M	38.59M	42.03M	48.70M	68.33M	21.13M	20.48M	-18.77M	-2.59M	53.95M
Dividends Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	0	0	0	0
FCF to OCF	105.32%	106.67%	116.36%	103.09%	222.52%	149.65%	171.71%	98.95%	105.98%	100.25%	211.15%	105.47%	115.13%	84.18%	90.70%	65.67%	81.70%	55.83%	91.20%	108.46%	144.35%	98.62%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00%	-	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Earnings

Report Date	Dec 31, 2011	Mar 31, 2012	Jun 30, 2012	Sep 30, 2012	Dec 31, 2012	Mar 31, 2013	Jun 30, 2013	Sep 30, 2013	Dec 31, 2013	Mar 31, 2014	Jun 30, 2014	Sep 30, 2014	Dec 31, 2014	Mar 31, 2015	Jun 30, 2015	Sep 30, 2015	Dec 31, 2015	Mar 31, 2016	Jun 30, 2016	Sep 30, 2016	Dec 31, 2016	Mar 31, 2017	Jun 30, 2017	Sep 30, 2017	Dec 31, 2017	Mar 31, 2018	Jun 30, 2018	Sep 30, 2018	Dec 31, 2018	Mar 31, 2019	Jun 30, 2019	Jul 26, 2019	Oct 24, 2019	Mar 5, 2020	May 14, 2020	Jul 30, 2020	Oct 29, 2020	Mar 4, 2021	May 13, 2021	Aug 5, 2021	Oct 28, 2021	Mar 17, 2022	May 12, 2022	Aug 4, 2022	Oct 27, 2022	Mar 16, 2023	May 11, 2023	Aug 3, 2023	Oct 26, 2023	Mar 14, 2024	May 8, 2024	Aug 1, 2024	Oct 24, 2024	Mar 12, 2025	May 8, 2025	Jul 31, 2025	Nov 6, 2025	Mar 12, 2026	May 7, 2026	Jul 30, 2026	Nov 5, 2026
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12	0.18	0.20	0.12	0.15	0.12	0.11	0.16	0.10	0.04	0.02	0.05	0.01	0.40	-0.21	-0.17	-0.02	-0.01	0.00	0.01	-0.00	-0.00	0.01	-0.02	-0.01	-0.13	0.01	0.01	0.20	0.10
EPS Actual	-0.11	-0.16	-0.21	-0.13	0.00	-0.06	-0.01	-0.02	-0.02	-0.06	-0.01	-0.00	0.05	-0.00	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.02	-0.01	-0.06	-0.02	-0.09	0.01	0.01	0.01	0.03	0.01	0.01	0.02	0.02	0.01	0.02	0.01	0.01	0.11	0.16	0.05	-0.00	0.01	0.01	0.01	0.01	-0.20	-0.02	0.01	0.01	-0.04	-0.02	-0.02	-0.02	0.01	-0.02	0.01	0.01	0.07	-0.07	0.02	-
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-85.58%	-88.72%	-93.95%	-86.75%	-92.20%	-89.00%	4.00%	-1.88%	-47.60%	-101.21%	-25.00%	-80.00%	0.00%	-97.50%	2.38%	88.24%	150.00%	200.00%	-1002.22%	-300.00%	-785.00%	-512.00%	-41.18%	0.00%	200.00%	108.00%	498.29%	-800.00%	-90.00%	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	-

Key Statistics & Ratios

Market Cap740.34M

Enterprise Value737.54M

Trailing P/E74.71

Forward P/E212.77

Price / Sales2.02

Price / Book2.95

EPS0.14

Book Value3.82

Revenue (TTM)366.48M

Gross Profit (TTM)317.08M

EBITDA32.88M

Profit Margin2.54%

Operating Margin1.46%

Return on Equity3.65%

Return on Assets3.47%

Shares Outstanding70.78M

Shares Float69.66M

Beta0.07

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Strong Buy

Based on 3 analystsTarget 34.35

Strong Buy
2
Buy
1

Ownership Breakdown

Institutions: 0.14%
Insiders: 0.00%
Retail / Other: 99.86%

Top Institutional Holders

MAC Alpha Capital Management, LP
2.15M3.04%
Silverberg Bernstein Capital Management LLC
41.55K0.06%
Crossmark Global Holdings, Inc.
12.46K0.02%
Citadel Advisors Llc
11.97K0.02%
Morgan Stanley - Brokerage Accounts
11.49K0.02%
SmartHarvest Portfolios, LLC
10.41K0.01%
Knoll Capital Management LP
4.06K0.01%
Goss Wealth Management LLC
2.15K0.00%
Global Retirement Partners, LLC.
4560.00%
BNP Paribas Arbitrage, SA
4000.00%
Integrated Wealth Concepts LLC
3800.00%
Larson Financial Group, LLC
3430.00%
Advisor Group Holdings, Inc.
1280.00%
EverSource Wealth Advisors, LLC
00.00%
Cornerstone Financial Management, LLC
00.00%
Stone House Investment Management, LLC
00.00%
UBS Group AG
00.00%
Millennium Management LLC
00.00%

Top Fund Holders

Steward Values Enhanced International I
12.46K0.02%
Fidelity Nasdaq Composite Index
2.09K0.00%